PB2003: REAL‐WORLD TREATMENT PATTERNS OF PATIENTS (PTS) WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROME (MDS) IN A US REAL‐WORLD EVIDENCE DATABASE (COTA)
Komrokji, Rami S., Hernandez‐ Donoso, Leyla, Hodzic, Sejla, Owusu, Henry, Nolan, Kevin, Nourry, Claire, Campelo, María Díez
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P541: REAL‐WORLD USE OF VENETOCLAX (VEN) IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) IN A US REAL‐WORLD EVIDENCE DATABASE (COTA)
Zeidan, Amer M., Hernandez‐ Donoso, Leyla, Hodzic, Sejla, Owusu, Henry, Pathak, Dhrubajyoti, Zhou, Summera, Stein, Eytan
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
AML-308 Real-World (RW) Outcomes With Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML) From COTA, a US RW Evidence Database
Stein, Eytan, Hodzic, Sejla, Owusu, Henry, Pathak, Dhrubajyoti, Zhou, Summera
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
POSTER: AML-308 Real-World (RW) Outcomes With Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML) From COTA, a US RW Evidence Database
Stein, Eytan, Hodzic, Sejla, Owusu, Henry, Pathak, Dhrubajyoti, Zhou, Summera
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Real-world (RW) treatment (tx) patterns of patients (pts) with higher-risk myelodysplastic syndrome (MDS) in a US RWE database (COTA)
Komrokji, Rami S., Hernandez Donoso, Leyla, Hodzic, Sejla, Owusu, Henry F, Nolan, Kevin, Nourry, Claire, Diez-Campelo, Maria
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Real-world (RW) use of venetoclax (VEN) in patients (pts) with acute myeloid leukemia (AML) in a US RWE database (COTA)
Zeidan, Amer Methqal, Hernandez Donoso, Leyla, Hodzic, Sejla, Owusu, Henry F, Pathak, Dhrubajyoti, Zhou, Summera Qiheng, Stein, Eytan
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Phase 3b Study Assessing the Safety and Efficacy of Midostaurin in Younger and Older Patients with Newly Diagnosed, FLT3-Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for 7+3 or 5+2 Chemotherapy
Sierra, Jorge, Montesinos, Pau, Thomas, Xavier, Griškevičius, Laimonas, Cluzeau, Thomas, Caillot, Denis, Legrand, Ollivier, Minotti, Clara, Luppi, Mario, Farkas, Firas, Bengoudifa, Bourras-Rezki, Gilotti, Geralyn, Hodzic, Sejla, Rambaldi, Alessandro, Venditti, Adriano
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
Sierra, Jorge, Montesinos, Pau, Thomas, Xavier, Griskevicius, Laimonas, Cluzeau, Thomas, Caillot, Denis, Legrand, Ollivier, Minotti, Clara, Luppi, Mario, Farkas, Firas, Bengoudifa, Bourras-Rezki, Gilotti, Geralyn, Hodzic, Sejla, Rambaldi, Alessandro, Venditti, Adriano
Published in Blood advances (14.11.2023)
Published in Blood advances (14.11.2023)
Get full text
Journal Article